Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
2016 · Nature Communications · 1,522 citations
https://doi.org/10.1038/ncomms10501
Y
Yvonne Y. Li
Broad Institute(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
221
Papers
7.8K
Citations
32
h-index
41
i10-index
Yvonne Y. Li is an academic researcher from Broad Institute. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers. The author has an h-index of 32, co-authored 188 publications.
Papers by this author
worksMicroenvironment drives cell state, plasticity, and drug response in pancreatic cancer
2021 · Cell · 537 citations
https://doi.org/10.1016/j.cell.2021.11.017
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
2017 · Nature Communications · 325 citations
https://doi.org/10.1038/ncomms14121
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC
2020 · Clinical Cancer Research · 210 citations
https://doi.org/10.1158/1078-0432.ccr-19-3608
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q
2020 · Cell Reports · 58 citations
https://doi.org/10.1016/j.celrep.2020.108493
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat